Publication scheme

NHS Kernow has followed guidance from the Information Commissioner and adopted its publication scheme for healthcare.
This scheme aims to provide you with information within the following categories:

Where possible, access to this information will be via our website. However, some information may only be available as hard copy or other media.

You can also check if the information has been published on our disclosure log, which contains responses to all our FOI requests.

Prescribing rebates
NHS Kernow has a policy to agree and consider future rebates, and has arrangements for the following drugs:

Company Product Type Start date End date Aligned to PrescQIPP
Aymes Oral nutritional supplements Oral nutritional supplements 01/01/2020 31/12/2020 Yes
Chiesi Ltd Clenil Modulite Inhaler 01/08/2019 30/07/2021 Yes
Fontus Health Ltd Zaluron XL ( Quetiapine XL) Anti-psychotic medicine 01/08/2019 30/07/2024 Yes
Ferring Pharmaceauticals FirmagonĀ® (degarelix) Treatment for prostate cancer 01/09/2019 31/08/2020 Yes
Aspire Pharma Ltd Quetiapine – Biquelle Atypical anti-psychotic medicine 01/04/2020 31/03/2021 Yes
DS Ashbourne Ltd (Part of the Ethypharm Group) Fencino Pain relief patch 01/04/2016 Rolling Yes
Ethypharm Pipexus For use in the treatment of Parkinson’s 01/07/2018 30/06/2020 Yes
Ethypharm Xaggitin Used to treat ADHD 01/08/2017 Rolling Yes
GlaxoSmithKline UK Ltd (GSK) Seretide Inhaler 17/10/2018 16/10/2020 Yes
Aventis Pharma Limited trading as Sanofi Aprida Insulin 01/04/2020 31/03/2021 Yes
Aventis Pharma Limited trading as Sanofi Insuman Insulin 01/04/2020 31/03/2021 Yes
Aventis Pharma Limited trading as Sanofi Lantus Insulin 01/04/2020 31/03/2021 Yes
Aventis Pharma Limited trading as Sanofi Lispro Insulin 01/04/2019 30/06/2020 Yes
Daiichi Sankyo Edexoban Anti coagulant 01/04/2018 31/12/2022 Yes
Boehringer – Ingleheim Spiolto Inhalation solution 19/06/2017 18/06/2020 – contract expired Yes
CIPLA Sereflo Inhaler 01/09/2019 31/08/2021 Yes
Almirall Ltd Balneum Emolient for eczema 23/06/2020 22/06/2022 Yes